Roche Holding | ROG - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
AbbVie USD -4.58B 1.35B 2026-09
Alcon AG USD 21.6B 538M 2026-06
Almirall EUR 1.53B 43.26M 2026-06
Amgen USD 14.35B 2.66B 2026-09
AstraZeneca USD 51.73B 1.43B 2026-09
Bayer EUR 29.18B 533M 2026-09
Biogen USD 19.04B 194.3M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Eli Lilly USD 40.27B 6.39B 2026-09
Fresenius EUR 20.51B 810M 2026-09
Fresenius Medical Care EUR 13.76B 226.23M 2026-09
Genmab DKK 5.96B 275M 2026-06
Gilead Sciences USD 13.04B 1.3B 2026-09
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
GRIFOLS EUR 5.79B 2.19B 2026-09
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Lonza CHF 9.13B 513M 2025-12
Merck EUR 30.17B 430M 2026-06
Merck USD 44.89B 2.96B 2026-09
Novartis USD 37.23B 4.72B 2026-09
Orion EUR 1.4B 129.5M 2026-09
Pfizer USD 89B 3.81B 2026-09
Philips EUR 11.61B 133M 2026-09
Recordati EUR 2.34B 209.24M 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.88B 3.31B 2026-09
UCB EUR 10.87B 1.18B 2025-12